CorMedix Inc. Announces New Commercial Agreement
September 19, 2024 08:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. to Present at the Cantor Global Healthcare Conference
September 13, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces New Commercial Agreement
September 09, 2024 10:52 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
August 14, 2024 07:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024
August 07, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces Outpatient Availability of DefenCath
July 03, 2024 08:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. Receives FDA Feedback on Potential Label Expansion
June 18, 2024 08:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
June 06, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for...
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider
May 28, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
CorMedix Inc. to Participate in Two Upcoming Investor Conferences
May 10, 2024 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 10, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening...